🚨 FDA keeps Tirzepatide on the shortage list. Also cites "steady and growing" demand from compounders like $HIMS as proof of shortage.
This bodes well for keeping Semaglutide on the shortage list aswell.
FDA to update on Dec 19, 2024.
🚨 FDA keeps Tirzepatide on the shortage list. Also cites "steady and growing" demand from compounders like $HIMS as proof of shortage.
This bodes well for keeping Semaglutide on the shortage list aswell.
FDA to update on Dec 19, 2024.